标题
Update on biomarkers for amyloid pathology in Alzheimer's disease
作者
关键词
-
出版物
Biomarkers in Medicine
Volume 12, Issue 7, Pages 799-812
出版商
Future Medicine Ltd
发表日期
2018-06-15
DOI
10.2217/bmm-2017-0433
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Mass Spectrometric Characterization of Amyloid-β Species in the 7PA2 Cell Model of Alzheimer's Disease
- (2018) Erik Portelius et al. JOURNAL OF ALZHEIMERS DISEASE
- Qualification of a Surrogate Matrix-Based Absolute Quantification Method for Amyloid-β42 in Human Cerebrospinal Fluid Using 2D UPLC-Tandem Mass Spectrometry
- (2018) Magdalena Korecka et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays
- (2018) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Prognostic value of amyloid PET scan in normal pressure hydrocephalus
- (2017) Hyemin Jang et al. JOURNAL OF NEUROLOGY
- In vivo staging of regional amyloid deposition
- (2017) Michel J. Grothe et al. NEUROLOGY
- Review: Tau in biofluids - relation to pathology, imaging and clinical features
- (2017) H. Zetterberg NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Aβ-amyloid and Tau Imaging in Dementia
- (2017) Victor L. Villemagne et al. SEMINARS IN NUCLEAR MEDICINE
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
- (2017) Ronald Lautner et al. Alzheimers Research & Therapy
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update
- (2017) Karim Farid et al. NeuroImage-Clinical
- Alzheimer's Disease and the Amyloid-β Peptide
- (2017) M. Paul Murphy et al. JOURNAL OF ALZHEIMERS DISEASE
- Proteome-Based Plasma Markers of Brain Amyloid-β Deposition in Non-Demented Older Individuals
- (2017) Madhav Thambisetty et al. JOURNAL OF ALZHEIMERS DISEASE
- A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
- (2017) Steve Pedrini et al. Scientific Reports
- Neuroimaging biomarkers in Alzheimer’s disease and other dementias
- (2016) Victor L. Villemagne et al. AGEING RESEARCH REVIEWS
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
- (2016) Sarah Westwood et al. JOURNAL OF ALZHEIMERS DISEASE
- Reference measurement procedure for CSF amyloid beta (Aβ)1-42and the CSF Aβ1-42/Aβ1-40ratio - a cross-validation study against amyloid PET
- (2016) Josef Pannee et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Predicting Alzheimer disease from a blood-based biomarker profile
- (2016) Samantha C. Burnham et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
- (2016) Dag Sehlin et al. Nature Communications
- Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
- (2016) Jaume Folch et al. NEURAL PLASTICITY
- Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins
- (2016) N Voyle et al. Translational Psychiatry
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Is amyloid-β harmful to the brain? Insights from human imaging studies
- (2015) William Jagust BRAIN
- The genetic landscape of Alzheimer disease: clinical implications and perspectives
- (2015) Caroline Van Cauwenberghe et al. GENETICS IN MEDICINE
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- η-Secretase processing of APP inhibits neuronal activity in the hippocampus
- (2015) Michael Willem et al. NATURE
- Plasma amyloid β—quo vadis?
- (2015) Henrik Zetterberg NEUROBIOLOGY OF AGING
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP)
- (2015) Christian B. Lessard et al. PLoS One
- Predicting Alzheimer disease with β-amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
- (2014) Christopher C. Rowe et al. ANNALS OF NEUROLOGY
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease
- (2014) Nicholas Myers et al. BRAIN
- Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid- in Cerebrospinal Fluid
- (2014) A. Leinenbach et al. CLINICAL CHEMISTRY
- A Sensitive A Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
- (2014) M. J. Savage et al. JOURNAL OF NEUROSCIENCE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism
- (2014) Ilie-Cosmin Stancu et al. Molecular Neurodegeneration
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel plasma biomarker surrogating cerebral amyloid deposition
- (2014) Naoki KANEKO et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
- (2014) Erik Portelius et al. Alzheimers Research & Therapy
- Alzheimer disease immunotherapeutics: Then and now
- (2014) Harashish Jindal et al. Human Vaccines & Immunotherapeutics
- Cerebral amyloid PET imaging in Alzheimer’s disease
- (2013) Clifford R. Jack et al. ACTA NEUROPATHOLOGICA
- The global prevalence of dementia: A systematic review and metaanalysis
- (2013) Martin Prince et al. Alzheimers & Dementia
- Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for -Amyloid Imaging in Aging and Dementia
- (2013) C. C. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- The amyloid cascade is not the only pathway to AD
- (2013) Gaël Chételat Nature Reviews Neurology
- Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
- (2013) Kaj Blennow et al. NEUROPSYCHOPHARMACOLOGY
- Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
- (2013) Mikko Hölttä et al. PLoS One
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
- (2013) T. L. S. Benzinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Changes in Amyloid- and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
- (2013) L. F. Maia et al. Science Translational Medicine
- 18F-florbetaben Aβ imaging in mild cognitive impairment
- (2013) Kevin Ong et al. Alzheimers Research & Therapy
- Brain Imaging in Alzheimer Disease
- (2013) K. A. Johnson et al. Cold Spring Harbor Perspectives in Medicine
- Fluid Biomarkers in Alzheimer Disease
- (2013) K. Blennow et al. Cold Spring Harbor Perspectives in Medicine
- Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
- (2013) Rik Vandenberghe et al. NeuroImage-Clinical
- Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study
- (2012) Milos D. Ikonomovic et al. ACTA NEUROPATHOLOGICA
- Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
- (2012) Nicolas Villain et al. BRAIN
- Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
- (2012) Paula Agostinho et al. CURRENT PHARMACEUTICAL DESIGN
- Novel AβIsoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment
- (2012) Erik Portelius et al. CURRENT PHARMACEUTICAL DESIGN
- An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid
- (2012) Gunnar Brinkmalm et al. JOURNAL OF MASS SPECTROMETRY
- Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
- (2012) David A Wolk et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals
- (2012) Reisa A. Sperling et al. NEUROBIOLOGY OF AGING
- Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
- (2012) M. Scholl et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
- (2011) Victor L. Villemagne et al. ANNALS OF NEUROLOGY
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
- (2011) G. D. Rabinovici et al. NEUROLOGY
- APP processing in Alzheimer's disease
- (2011) Yun-wu Zhang et al. Molecular Brain
- Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
- (2010) Ahmadul Kadir et al. BRAIN
- Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers
- (2010) William D. Knight et al. BRAIN
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB
- (2010) S. M. Resnick et al. NEUROLOGY
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
- (2010) Erik Portelius et al. Alzheimers Research & Therapy
- High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types
- (2009) Victor L. Villemagne et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
- (2009) N. Nelissen et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Properties of 18F-AV-45: A PET Agent for A Plaques in the Brain
- (2009) S. R. Choi et al. JOURNAL OF NUCLEAR MEDICINE
- Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation
- (2009) Michael Schöll et al. NEUROBIOLOGY OF AGING
- Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid
- (2009) Erik Portelius et al. Neurodegenerative Diseases
- Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls
- (2009) N. M. Scheinin et al. NEUROLOGY
- An Overview of APP Processing Enzymes and Products
- (2009) Vivian W. Chow et al. NEUROMOLECULAR MEDICINE
- Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
- (2009) Reisa A. Sperling et al. NEURON
- Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
- (2008) Gil D. Rabinovici et al. ANNALS OF NEUROLOGY
- A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia
- (2008) Takami Tomiyama et al. ANNALS OF NEUROLOGY
- Carbon 11–Labeled Pittsburgh Compound B Positron Emission Tomographic Amyloid Imaging in Patients With APP Locus Duplication
- (2008) Anne M. Remes et al. ARCHIVES OF NEUROLOGY
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
- (2008) Howard Jay Aizenstein et al. ARCHIVES OF NEUROLOGY
- Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
- (2008) Henrik Zetterberg et al. ARCHIVES OF NEUROLOGY
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
- (2008) Dennis J. Selkoe BEHAVIOURAL BRAIN RESEARCH
- PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease
- (2008) J. Koivunen et al. BRAIN
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
- (2008) E. C. Mormino et al. BRAIN
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- Reassessing the amyloid cascade hypothesis of Alzheimer's disease
- (2008) Sanjay W. Pimplikar INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
- Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
- (2008) V.L. Villemagne et al. NEUROPSYCHOLOGIA
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now